JAMA Dermatology
Tracked across 1 events · 7 articles · First seen Aug 26, 2026 · Last active Aug 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: JAMA Dermatology published the skin-specific outcomes from the VALOR trial, providing peer-reviewed validation of the results. This enhances the scientific credibility of brepocitinib.
Aug 26, 2026 · 7 articles
ERGEN INTELLIGENCE
Track JAMA Dermatology live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard